Copyright
©2007 Baishideng Publishing Group Co.
World J Gastroenterol. Jun 7, 2007; 13(21): 2945-2951
Published online Jun 7, 2007. doi: 10.3748/wjg.v13.i21.2945
Published online Jun 7, 2007. doi: 10.3748/wjg.v13.i21.2945
Table 1 Patients characteristics. Data shown are number (%) or median (range)
| Characteristic | CRR | RO | P |
| n | 22 | 25 | NS |
| Age | 65 (49-83) | 63 (43-76) | NS |
| Sex (male) | 13 (59%) | 12 (48%) | NS |
| Tumor site | NS | ||
| Head | 20 (91%) | 20 (80%) | |
| Body | 3 (12%) | ||
| Tail | |||
| Diffuse | 2 (9%) | 2 (8%) | |
| Tumor size (mm) | 24 (10-41) | 29 (10-150) | NS |
| Tumor type | NS | ||
| Ampullary cancer | 4 (18%) | 4 (16%) | |
| Ductal adenocarcinoma | 15 (68%) | 14 (56%) | |
| Cystadenocarcinoma | 2 (9%) | 4 (16%) | |
| Invasive IPMT | 1 (5%) | 3 (12%) | |
| Tumor stage | NS | ||
| IA | 4 (18%) | 0 | |
| IB | 4 (18%) | 5 (20%) | |
| IIA | 7 (32%) | 9 (36%) | |
| IIB | 7 (32%) | 11 (44%) | |
| Lymph node positive | 7 (32%) | 11 (44%) | NS |
- Citation: Vento P, Mustonen H, Joensuu T, Kärkkäinen P, Kivilaakso E, Kiviluoto T. Impact of preoperative chemoradiotherapy on survival in patients with resectable pancreatic cancer. World J Gastroenterol 2007; 13(21): 2945-2951
- URL: https://www.wjgnet.com/1007-9327/full/v13/i21/2945.htm
- DOI: https://dx.doi.org/10.3748/wjg.v13.i21.2945